The Center for Genetic Engineering and Biotechnology (CIGB) is a distinctive Cuban biotechnology company, which investigates, develops, produces and markets novel biotechnological applications and preventive, therapeutic and diagnostic biopharmaceutical products, for the biomedical, agricultural and industrial sectors, for one health.
Our mission is to research, develop, produce and commercialize novel biotechnological and pharmaceutical products, with a positive impact on human, animal and plant health, and on industrial productions, in harmony with the environment. Contribute to the socioeconomic development of Cuba.
Our vision is to maintain leadership as one of the companies with the greatest scientific-technical contribution to health, and to achieve a solid international position with biotechnological innovation, in harmony with the environment, for sustainable socioeconomic development.
Our company encourages and strengthens values shared by the majority of workers, which contribute to a motivational, innovative and participatory climate, and favor the quality of work, productivity and competitiveness, in order to solve health and nutrition problems that plague Cuba and the world:
It researches, develops, produces and markets innovative biotechnological products, focused on the agricultural sector and in the field of hormone-sensitive tumor therapies. Its main product is the recombinant vaccine for the control of ticks in cattle Gavac®. […]
The headquarters of the Center for Genetic Engineering and Biotechnology in the Cuban province of Sancti Spíritus specializes in research, development and production of diagnostics and biological reagents, as well as agricultural biotechnological research Founded 30 years […]